These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17262907)

  • 1. RNAi therapeutics: can siRNAs conquer SARS?
    Chang Z; Hu Z
    Gene Ther; 2006 Jun; 13(11):871-2. PubMed ID: 17262907
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication.
    He ML; Zheng BJ; Chen Y; Wong KL; Huang JD; Lin MC; Yuen KY; Sung JJ; Kung HF
    Hong Kong Med J; 2009 Jun; 15(3 Suppl 4):28-31. PubMed ID: 19509435
    [No Abstract]   [Full Text] [Related]  

  • 3. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
    Li BJ; Tang Q; Cheng D; Qin C; Xie FY; Wei Q; Xu J; Liu Y; Zheng BJ; Woodle MC; Zhong N; Lu PY
    Nat Med; 2005 Sep; 11(9):944-51. PubMed ID: 16116432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent patents on treatment of severe acute respiratory syndrome (SARS).
    Zhai S; Liu W; Yan B
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):1-10. PubMed ID: 18221160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spike protein of SARS-CoV--a target for vaccine and therapeutic development.
    Du L; He Y; Zhou Y; Liu S; Zheng BJ; Jiang S
    Nat Rev Microbiol; 2009 Mar; 7(3):226-36. PubMed ID: 19198616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.
    Wang Z; Ren L; Zhao X; Hung T; Meng A; Wang J; Chen YG
    J Virol; 2004 Jul; 78(14):7523-7. PubMed ID: 15220426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of siRNA against SARS in the rhesus macaque model.
    Tang Q; Li B; Woodle M; Lu PY
    Methods Mol Biol; 2008; 442():139-58. PubMed ID: 18369784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
    Yeung KS; Meanwell NA
    Infect Disord Drug Targets; 2007 Mar; 7(1):29-41. PubMed ID: 17346209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus.
    He ML; Zheng BJ; Chen Y; Wong KL; Huang JD; Lin MC; Peng Y; Yuen KY; Sung JJ; Kung HF
    FEBS Lett; 2006 May; 580(10):2414-20. PubMed ID: 16638566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.
    Zhang Y; Li T; Fu L; Yu C; Li Y; Xu X; Wang Y; Ning H; Zhang S; Chen W; Babiuk LA; Chang Z
    FEBS Lett; 2004 Feb; 560(1-3):141-6. PubMed ID: 14988013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of SARS-CoV replication by siRNA.
    Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
    Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS coronavirus: a new challenge for prevention and therapy.
    Holmes KV
    J Clin Invest; 2003 Jun; 111(11):1605-9. PubMed ID: 12782660
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-associated coronavirus.
    Holmes KV
    N Engl J Med; 2003 May; 348(20):1948-51. PubMed ID: 12748314
    [No Abstract]   [Full Text] [Related]  

  • 14. [The research and application of inhibitory effect of RNA-based strategies on SARS].
    Chen J; Cai HR; Li QH
    Bing Du Xue Bao; 2010 Jul; 26(4):336-9. PubMed ID: 20836389
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.
    Akerström S; Mirazimi A; Tan YJ
    Antiviral Res; 2007 Mar; 73(3):219-27. PubMed ID: 17112601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.
    Neuman BW; Stein DA; Kroeker AD; Moulton HM; Bestwick RK; Iversen PL; Buchmeier MJ
    Adv Exp Med Biol; 2006; 581():567-71. PubMed ID: 17037599
    [No Abstract]   [Full Text] [Related]  

  • 17. [SARS-CoV: 1. The virus].
    Tratner I
    Med Sci (Paris); 2003; 19(8-9):885-91. PubMed ID: 14593622
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus.
    Zheng BJ; Guan Y; Tang Q; Du C; Xie FY; He ML; Chan KW; Wong KL; Lader E; Woodle MC; Lu PY; Li B; Zhong N
    Antivir Ther; 2004 Jun; 9(3):365-74. PubMed ID: 15259899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus of the management of severe acute respiratory syndrome].
    Chinese Medical Association, China Association of Chinese Medicine
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1731-52. PubMed ID: 14723215
    [No Abstract]   [Full Text] [Related]  

  • 20. [RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells].
    Zhu XD; Dang Y; Feng Y; Li T; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):484-9. PubMed ID: 15968975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.